Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2026-01-01 @ 8:42 PM
Study NCT ID:
NCT04380961
Status:
COMPLETED
Last Update Posted:
2022-06-21
First Post:
2020-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-07
First Submit QC Date:
None
Study First Post Date:
2020-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-04-08
Results First Submit QC Date:
None
Results First Post Date:
2022-06-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-23
Last Update Post Date:
2022-06-21
Last Update Post Date Type:
ACTUAL